What is Talosix?
Talosix offers an advanced AI-powered platform engineered to revolutionize clinical trial processes. The company specializes in enhancing patient recruitment and providing technology-driven study management solutions. Its services are tailored for sponsors, contract research organizations (CROs), and healthcare providers, aiming to streamline clinical research operations. The platform integrates tools for patient screening, data collection, and compliance, utilizing artificial intelligence for superior data analysis and reporting. Talosix's core mission is to efficiently connect patients with suitable clinical trials, thereby maximizing study potential through real-time insights and personalized engagement strategies.
How much funding has Talosix raised?
Talosix has raised a total of $235K across 1 funding round:
Debt
$235K
Debt (2021): $235K with participation from PPP
Key Investors in Talosix
PPP
Public-Private Partnership
What's next for Talosix?
With its substantial late-stage funding, Talosix is poised to accelerate its market penetration and further develop its AI capabilities. The strategic investment will likely fuel enhancements in platform technology, expand its service offerings, and bolster its sales and marketing efforts to reach a broader client base within the pharmaceutical and healthcare sectors. Future developments may include deeper integration with electronic health record systems and advanced predictive analytics for trial success rates, solidifying its role as a key innovator in clinical research technology.
See full Talosix company page
